Skip to main content

Exploring Public Policy: Regenerative Medicine and Cell Therapies: A Virtual Event



    Exploring Public Policy: Regenerative Medicine and Cell Therapies
A Virtual Event
September 16, 2020, 9am to 5:45pm ET

  • 1. Opening Remarks – 9:00am – 9:05am ET
Janet Marchibroda
President, Alliance for Cell Therapy Now
Bernard Siegel
Executive Director, Regenerative Medicine Foundation
Founder and Chair, World Stem Cell Summit
  • 2. Overview of the Landscape: Regenerative Medicine and Cell Therapies – 9:05am – 9:35am ET
Julie Allickson, PhD, Chief, Manufacturing Development Center Officer, Wake Forest Institute for Regenerative Medicine
Colleen Delaney, MD, Founder, Chief Scientific Officer and Executive Vice President of Research and Development, Deverra Therapeutics and Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Washington
Joanne Kurtzberg, MD, Jerome Harris Distinguished Professor of Pediatrics; Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program; Director, Carolinas Cord Blood Bank; Co-Director, Stem Cell Transplant Laboratory; Duke University Medical Center; President, Cord Blood Association
Moderated by:
Max Gomez, MD, Award-Winning Broadcast Journalist, CBS News Medical Correspondent
  • 3. Insights on Outcomes from Use of MSCs for Patients with COVID-19 – 9:40am – 10:40am ET
Joshua M. Hare, MD, FACC, FAHA, Louis Lemberg Professor of Medicine, Founding Director, Interdisciplinary Stem Cell Institute, University of Miami, Miller School of Medicine
Joanne Kurtzberg, MD, Jerome Harris Distinguished Professor of Pediatrics; Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program; Director, Carolinas Cord Blood Bank; Co-Director, Stem Cell Transplant Laboratory; Duke University Medical Center; President, Cord Blood Association
Michael Matthay, MD, Professor in Residence, Associate Director, Critical Care Medicine; Research Lab Director, Acute Lung Injury and ARDS: Research and Clinical Trials, University of California – San Francisco
Wenchun Qu, MD, PhD, Associate Professor of Anesthesiology; Associate Professor of Physical Medicine and Rehabilitation; Physiatrist and Pain Specialist, Director, Mayo Allogeneic Cell Therapy Program, Mayo Clinic
Moderated by:
Fred Sanfilippo, MD, PhD, Professor of Pathology and Laboratory Medicine, and Health Policy and Management, Emory University; Director, Emory-Georgia Tech Healthcare Innovation Program; Medical Director, The Marcus Foundation
  • 5. The Role of Government in Advancing Clinical Trials and Research – 10:50am – 11:50pm ET
Steven Becker, PhD
Director, Office of Regenerative Medicine, National Eye Institute, National Institutes of Health
Maria T. Millan, MD
President and CEO, California Institute for Regenerative Medicine
Audrey Kusiak, PhD
Scientific Program Manager, Rehabilitation Research and Development Service,
Office of Research and Development, Department of Veterans Affairs
Moderated by:
Anthony Atala, MD
G. Link Professor and Director, Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of Urology, Wake Forest School of Medicine
  • 6. Virtual Fireside Chat with Current and Former Administration Leaders – 12:00 – 1:00pm
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Robert Califf, MD, PhD
Head of Health Strategy and Policy, Google and Verily Health; Former Commissioner, Food and Drug Administration
Andrew von Eschenbach, MD
President, Samaritan Health Initiatives, Inc.; Adjunct Professor, University of Texas MD Anderson Cancer Center; Former Commissioner, Food and Drug Administration; Former Director, National Cancer Institute
Moderated by:
Mark McClellan, MD, PhD
Robert J. Margolis Professor of Business, Medicine, and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University; Former Commissioner, Food and Drug Administration; Former Administrator, Centers for Medicare and Medicaid Services
  • 7. Conversation with Industry Leader – 1:10pm – 1:30pm ET
David Oxley, Senior Vice President, Business Development and Licensing, Mesoblast
Moderated by:
Bernard Siegel, Executive Director, Regenerative Medicine; Founder and Chair, World Stem Cell Summit
  • 8. Update from Capitol Hill – 1:35pm – 2:20pm ET
Garrett Devenney, Office of Senator Patty Murray (D-WA), Ranking Member, Senate Health, Education, Labor, and Pensions Committee
Andrew Vogt, Office of Senator Lamar Alexander (R-TN), Chairman, Senate Health, Education, Labor, and Pensions Committee
Moderated by:
Janet Marchibroda
President, Alliance for Cell Therapy Now
  • 9. Scaling Manufacturing of Cell Therapies: Current Capabilities, Key Strategies for Moving Forward – 2:30pm – 3:20pm ET
John McMannis, PhD, Executive Vice President, Manufacturing, Mesoblast
Lisa McClain-Moss, Senior Director, Manufacturing, Longeveron
Jon A. Rowley, PhD, Founder and Chief Product Officer, RoosterBio Inc.
Moderated by:
Krishnendu Roy, PhD, Robert A. Milton Chair; Director, NSF Engineering Research Center for Cell Manufacturing Technologies; Director, Marcus Center for Cell-Therapy Characterization and Manufacturing; Technical Lead, National Cell Manufacturing Consortium; Director, Center for ImmunoEngineering, Georgia Institute of Technology
  • 10. Examining Workforce: Where We Are Today; Key Actions Needed – 3:30pm – 3:50pm ET
Gary Green
Chief Workforce Development Officer, Regenerative Medicine Development Organization
Moderated by:
Bernard Siegel
Executive Director, Regenerative Medicine Foundation
  • 11. Roundtable Discussion: Policy Actions Needed to Advance Regenerative Medicine and Cell Therapies – 4:00pm – 5:00pm ET
Julie G. Allickson, PhD
Chief, Manufacturing Development Center Officer, Wake Forest Institute for Regenerative Medicine
Arnold Caplan, PhD
Professor of Biology and the Director of the Skeletal Research Center, Case Western Reserve University
George J.Christ, PhD, Professor of Biomedical Engineering and Orthopaedic Surgery; Mary Muilenburg Stamp Professor of Orthopaedic Research; Director of Basic and Translational Research in Orthopaedic Surgery; Head, Laboratory of Regenerative Therapeutics; University of Virginia School of Engineering and Applied Sciences
Keith March, MD, PhD
Director, University of Florida Center for Regenerative Medicine; Vice Chief, Cardiology Research; and Professor in the UF Division of Cardiovascular Medicine and UF Department of Medicine
David A. Pearce, PhD
President of Innovation, Research, and World Clinic, Sanford Health; Senior Scientist, Sanford Children’s Health Research Center; Professor of Pediatrics, University of South Dakota Sanford School of Medicine
Ricardo Rodriguez, MD
Medical Director, Cosmeticsurg.net; Member, Regenerative Medicine Task Force, American Society of Plastic Surgeons; Former President, International Federation for Adipose Therapeutics and Science (IFATS)
Moderated by:
Robin L. Smith, MD, MBA
President and Chair, Stem for Life and Cura Foundation
  • 12. NFL Alumni’s Work in Regenerative Medicine and Cell Therapies – 5:00pm - 5:40pm ET
Billy Davis
Co-Director, Healthcare Initiatives, NFL Alumni
Tiffany Facile
Director of Clinical Regenerative Medicine, Sanford Health
Jaime R. Garza, MD, DDS, FACS, Professor of Orthopedic Surgery, Professor of Otolaryngology, and Director of Human Regenerative Cell Trials at Tulane University School of Medicine
Kyle Richardson
Board Member, Co-Director, Healthcare Initiatives, NFL Alumni; Former Player, NFL
Moderated by:
Janet Marchibroda
President, Alliance for Cell Therapy Now
  • 13. Closing Remarks and Adjourn – 5:40pm – 5:45pm ET
Joanne Kurtzberg, MD
President, Cord Blood Association
Bernard Siegel
Executive Director, Regenerative Medicine Foundation
Founder and Chair, World Stem Cell Summit
Janet Marchibroda
President, Alliance for Cell Therapy Now